is a physicist with the Food and Drug Administration’s (FDA) Center for Devices and Radiological Health. On his arrival at the FDA in 1994, Dr. Spelic became involved with the Agency’s implementation of the Mammography Quality Standards Act (MQSA), particularly focusing on mammography physics testing and the training of MQSA inspectors.

Presently Dr. Spelic conducts premarket reviews of diagnostic x-ray devices, and directs most technical aspects of the Nationwide Evaluation of X-Ray Trends (NEXT) program, an FDA collaboration with the Conference of Radiation Control Program Directors to document trends in patient dose and image quality for selected diagnostic x-ray exams and procedures.